When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VCNX - Vaccinex adds to rally ahead of expected readout from Huntington's study
Vaccinex Inc.
Vaccinex (VCNX+18.3%) is up again, although 19% off the intraday high of $6.64, adding to its week-long rally after announcing that it remains on track to complete the pivotal Phase 2 SIGNAL study evaluating lead drug pepinemab in Huntington's disease patients on schedule. Shares have rallied almost 50% since then.
More news on: Vaccinex, Inc., Healthcare stocks news, Stocks on the move,